Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
Publication Date: April 1, 2018
Last Updated: March 14, 2022
Recommendations
1.0 Administration of Thromboprophylaxis
1.1 For each of the antithrombotic agents, we recommend that clinicians follow the FDA-approved dosing and ACCP management guidelines. (1A)
315340
Title
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
Authoring Organization
American Society of Regional Anesthesia and Pain Medicine